ReviewAntioxidants (Basel, Switzerland)2023

Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease.

Waseem Chauhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.